Growth Metrics

Axogen (AXGN) Shares Outstanding (Weighted Average) (2010 - 2026)

Axogen's quarterly Shares Outstanding (Weighted Average) came in at $51.6 million in Q1 2026, up 14.13% year-on-year from $45.2 million in Q1 2025, and up 12.03% quarter-over-quarter from $46.1 million in Q4 2025.

Axogen has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $51.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 14.13% year-over-year to $51.6 million; the trailing twelve-month figure through Mar 2026 stood at $51.6 million (up 14.13% YoY), and the FY2025 full-year result was $46.1 million, up 4.05% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $51.6 million, up from $46.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $51.6 million in Q1 2026, with the low at $41.8 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $44.0 million, with a median of $43.2 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) increased 1.56% in 2024 and advanced 14.13% in 2026.
  • Tracing AXGN's Shares Outstanding (Weighted Average) over 5 years: stood at $42.1 million in 2022, then climbed by 1.89% to $42.9 million in 2023, then climbed by 3.22% to $44.3 million in 2024, then grew by 4.05% to $46.1 million in 2025, then advanced by 12.03% to $51.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $51.6 million (Q1 2026), $46.1 million (Q4 2025), and $46.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn 51.59 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 51.59 Mn
Dec 31, 2025 46.05 Mn
Sep 30, 2025 46.49 Mn
Jun 30, 2025 45.61 Mn
Mar 31, 2025 45.20 Mn
Dec 31, 2024 44.26 Mn
Sep 30, 2024 43.61 Mn
Jun 30, 2024 43.71 Mn
Mar 31, 2024 43.23 Mn
Dec 31, 2023 42.88 Mn
Sep 30, 2023 42.82 Mn
Jun 30, 2023 42.86 Mn
Mar 31, 2023 42.57 Mn
Dec 31, 2022 42.08 Mn
Sep 30, 2022 42.01 Mn
Jun 30, 2022 41.90 Mn
Mar 31, 2022 41.80 Mn
Dec 31, 2021 41.21 Mn
Sep 30, 2021 41.09 Mn
Jun 30, 2021 41.08 Mn
Mar 31, 2021 40.71 Mn
Dec 31, 2020 39.97 Mn
Sep 30, 2020 40.09 Mn
Jun 30, 2020 39.82 Mn
Mar 31, 2020 39.70 Mn
Dec 31, 2019 39.24 Mn
Sep 30, 2019 39.15 Mn
Jun 30, 2019 39.06 Mn
Mar 31, 2019 38.93 Mn
Dec 31, 2018 37.13 Mn
Sep 30, 2018 38.50 Mn
Jun 30, 2018 35.61 Mn
Mar 31, 2018 34.52 Mn
Dec 31, 2017 33,323.00
Sep 30, 2017 33.29 Mn
Jun 30, 2017 33.08 Mn
Mar 31, 2017 33.03 Mn
Dec 31, 2016 30,702.00
Sep 30, 2016 30.08 Mn
Jun 30, 2016 30.08 Mn
Mar 31, 2016 29.99 Mn
Dec 31, 2015 26.08 Mn
Sep 30, 2015 26.84 Mn
Jun 30, 2015 24.93 Mn
Mar 31, 2015 22.52 Mn
Dec 31, 2014 17.72 Mn
Sep 30, 2014 17.47 Mn
Jun 30, 2014 17.42 Mn
Mar 31, 2014 17.38 Mn
Dec 31, 2013 13.50 Mn
Sep 30, 2013 14.32 Mn
Jun 30, 2013 11.13 Mn
Mar 31, 2013 11.12 Mn
Dec 31, 2012 11.09 Mn
Sep 30, 2012 11.10 Mn
Jun 30, 2012 11.08 Mn
Mar 31, 2012 11.06 Mn
Dec 31, 2011 3.70 Mn
Sep 30, 2011 1.32 Mn
Jun 30, 2011 1.21 Mn
Mar 31, 2011 1.21 Mn
Dec 31, 2010 41.56 Mn
Sep 30, 2010 1.19 Mn
Jun 30, 2010 4.31 Mn